Chamber announced it raised $60 million in Series A financing to expand its value-based care infrastructure for cardiology, supporting health plans and cardiology practices in the long-term management of cardiovascular disease. The round was led by Frist Cressey Ventures, with participation from existing investors including General Catalyst, AlleyCorp, American Family Ventures, and Company Ventures, as well as strategic participation from Optum Ventures and Healthworx Ventures, plus additional investment from Black Opal Ventures. The financing also included debt from HSBC Innovation Banking.
The funding will be used to deepen partnerships with payers and cardiology practices, expand into additional markets, and grow its clinical, operational, and technology teams as it scales.
The company cited its offering as a cardiology-focused data and intelligence platform embedded in existing clinical workflows, using workflow-native AI to prioritize high-risk patients, identify gaps in guideline-directed therapy, and reduce manual chart review.
Chamber’s operational infrastructure is designed to reduce preventable complications and hospital use, improve patient experience, and provide health plans with clearer visibility into cardiovascular performance and total cost of care.
Chamber currently supports patients through multiple payer partnerships and works with a network of more than 500 cardiologists across seven states, with plans for continued national expansion.
KEY QUOTES
“Chamber is focused on building the infrastructure that helps cardiologists succeed in value-based care, supports more predictable performance for health plans, and ultimately delivers a better experience for patients with heart disease.”
George Aloth, Co-Founder and CEO of Chamber
“Cardiovascular care generates enormous amounts of data, but clinicians don’t need more data but rather a clearer signal,”
Sameer Sheth, M.D., Co-Founder, President & CMO of Chamber
“At FCV, we invest in companies transforming care delivery in healthcare’s most consequential areas, and Chamber exemplifies that mission,” said Senator Bill Frist, M.D., Co-Founder and Managing Partner at Frist Cressey Ventures and a nationally recognized heart and lung transplant surgeon. “Cardiovascular disease is the largest driver of U.S. healthcare spend, yet care delivery remains fragmented and fee-for-service–driven. The Chamber platform brings value-based care to cardiology, delivering better outcomes and improved quality of life for patients and their families.”
Senator Bill Frist, M.D., Co-Founder and Managing Partner at Frist Cressey Ventures and a nationally recognized heart and lung transplant surgeon
